In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co‐infection

The −1G mutant HBV is more prevalent in individuals co‐infected with HIV/HBV than in individuals infected with HBV alone and in some cases is the dominant virus in circulation. This mutant is created by the deletion of a dGMP (−1G) from the guanine rich homopolymer sequence located at nts 2,085–2,090 (numbering from EcoRI site as position 1) in the HBV core gene. This deletion causes a frameshift generating a premature stop codon at 64Asn in the HBV core gene (codon 93 in the precore gene), that truncates the precore protein, precursor of the secreted hepatitis B “e” antigen (HBeAg), and the core protein which forms the viral nucleocapsid. However, the replication phenotype of the −1G mutant HBV is unknown. An in vitro cell culture model in which hepatoma cells were transiently transfected with infectious cDNAs was used to show that the −1G mutant HBV is incapable of autonomous replication and, as expected, replication was restored to wild‐type (wt) levels by supplying HBV core protein in trans. Although the −1G mutation had no deleterious effect on intracellular HBV‐DNA levels, high levels of −1G mutant HBV relative to wt HBV reduced virus secretion and HBeAg secretion relative to empty vector controls. Importantly, the −1G mutant HBV also caused intracellular retention of truncated precore protein in the endoplasmic reticulum (ER) and Golgi apparatus. Together, these effects may be contributing to the increased pathology observed in the setting of HIV/HBV co‐infection. J. Med. Virol. 84: 1166–1176, 2012. © 2012 Wiley Periodicals, Inc.

[1]  S. Locarnini,et al.  The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. , 2011, Journal of hepatology.

[2]  P. Revill,et al.  The hepatitis B e antigen suppresses IL‐1β‐mediated NF‐κB activation in hepatocytes , 2011, Journal of viral hepatitis.

[3]  Suha M. Saleh,et al.  Coinfection of Hepatic Cell Lines with Human Immunodeficiency Virus and Hepatitis B Virus Leads to an Increase in Intracellular Hepatitis B Surface Antigen , 2010, Journal of Virology.

[4]  P. Revill,et al.  Bioinformatic analysis of the hepadnavirus e‐antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses , 2010, Journal of medical virology.

[5]  B. McMahon,et al.  Chronic hepatitis B: Update 2009 , 2009, Hepatology.

[6]  Y. Kondo,et al.  A case of HIV co‐infected with hepatitis B virus precore/core deletion mutant treated by entecavir , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  N. Warner,et al.  The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound , 2008, Hepatology.

[8]  P. Marcellin,et al.  HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa‐2a for HBeAg‐positive chronic hepatitis B , 2008, Hepatology.

[9]  S. Lewin,et al.  Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals , 2007, AIDS.

[10]  R. D. de Man,et al.  Future prospectives for the management of chronic hepatitis B. , 2007, World journal of gastroenterology.

[11]  S. Lewin,et al.  Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.

[12]  G. Kristiansen,et al.  Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. , 2006, Gastroenterology.

[13]  Robert Y. L. Wang,et al.  Reduced Secretion of Virions and Hepatitis B Virus (HBV) Surface Antigen of a Naturally Occurring HBV Variant Correlates with the Accumulation of the Small S Envelope Protein in the Endoplasmic Reticulum and Golgi Apparatus , 2005, Journal of Virology.

[14]  D. Scheuner,et al.  The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. , 2005, The Journal of clinical investigation.

[15]  D. Lavanchy,et al.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.

[16]  Chien-Fu Chen,et al.  Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. , 2003, The American journal of pathology.

[17]  H. Isom,et al.  Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine‐resistant HBV in vitro , 2003, Hepatology.

[18]  S. Sarin,et al.  Hepatitis B e‐antigen negative chronic hepatitis B , 2002, Journal of gastroenterology and hepatology.

[19]  J. Phair,et al.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.

[20]  M. Manns,et al.  In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to (−)-β-d-2,6-Diaminopurine Dioxolane and 2′-Fluoro-5-Methyl-β-l-Arabinofuranosyluracil , 2001, Antimicrobial Agents and Chemotherapy.

[21]  S. Günther,et al.  Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. , 2000, Virology.

[22]  Anne Bertolotti,et al.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response , 2000, Nature Cell Biology.

[23]  G. Norkrans,et al.  HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. , 1999, Liver.

[24]  M. Loriot,et al.  Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men , 1999, Hepatology.

[25]  M. Manns,et al.  A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. , 1997, Gastroenterology.

[26]  R. Tedder,et al.  Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection , 1997, AIDS.

[27]  J. Wands,et al.  Posttranscriptional regulation of hepatitis B virus replication by the precore protein , 1997, Journal of virology.

[28]  J. Price,et al.  Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Gelmann,et al.  Hepatitis B virus infection in the acquired immunodeficiency syndrome. , 1984, Annals of internal medicine.

[30]  M. Skelton,et al.  Distinct mutant hepatitis B virus genomes, with alterations in all four open reading frames, in a single South African hepatocellular carcinoma patient. , 2012, Virus research.

[31]  Kui Li,et al.  The hepatitis B e antigen suppresses IL-1 beta-mediated NF-kappa B activation in hepatocytes , 2011 .

[32]  Norman Gitlin,et al.  Chronic hepatitis B : an update , 2010 .

[33]  M. Manns,et al.  In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. , 2001, Antimicrobial agents and chemotherapy.